Plipastatin A1

• UNSPSC Description:

  Plipastatin A1 is a lipopeptide with enzyme inhibitory and immunosuppressive activities. Plipastatin A1 is found in Bacillus cereus and inhibits phospholipase A2 (PLA2), PLC, and PLD[1].

• Target Antigen:

  Phospholipase

• Type:

  Peptides

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/plipastatin-a1.html

• Smiles:

  O=C1N2[C@](CCC2)([H])C(N[C@H](C(N[C@@H](C(N[C@@](C(OC3=CC=C(C[C@@H](C(N[C@](C(N[C@H](C(N[C@@H]1C)=O)CCC(O)=O)=O)([H])[C@H](O)C)=O)NC([C@@H](CCCN)NC([C@H](CCC(O)=O)NC(C[C@H](O)CCCCCCCCCCCCC)=O)=O)=O)C=C3)=O)([H])[C@@H](C)CC)=O)CC4=CC=C(C=C4)O)=O)CCC(N)=O)=O

• Molecular Weight:

  1463.71

• References & Citations:

  [1]Honma M, et al. Termination of the structural confusion between plipastatin A1 and fengycin IX. Bioorg Med Chem. 2012 Jun 15;20(12):3793-8.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  103651-09-8